Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers

18 Aug 2021

Abstract excerpt

Definition of therapy-related myeloid neoplasms (TRMN) is only based on clinical history of exposure to leukemogenic therapy. No specific molecular classification combining therapy-related acute myeloid leukemia and therapy-related myelodysplastic syndromes has been proposed. We aimed to describe the molecular landscape of TRMN at diagnosis, among 77 patients with previous gynecologic and breast cancer with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Lymphoma Diagnosis and Treatment
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34423258
DOI: 10.1097/hs9.0000000000000632

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast CancersPMID 34423258Read ↗

The role of clonal progression leading to the development of therapy-related myeloid neoplasms.Semantic proximity Read ↗

What's new in the pathogenesis and treatment of therapy-related myeloid neoplasms.Semantic proximity Read ↗

Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.Semantic proximity Read ↗

Therapy-Related Myeloid Neoplasm: Biology and Mechanistic Aspects of Malignant ProgressionSemantic proximity Read ↗

Next generation sequencing in therapy-related myeloid neoplasms compared to de novo myeloid neoplasms.Semantic proximity Read ↗

The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionSemantic proximity Read ↗

Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic.Semantic proximity Read ↗

Therapy-related myeloid neoplasms.Semantic proximity Read ↗

Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.Semantic proximity Read ↗

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.Semantic proximity Read ↗

Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies?Semantic proximity Read ↗

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical TrialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.